Clearside Biomedical Inc buy Chardan Capital
Start price
28.03.25
/
50%
€0.86
Target price
28.03.26
€5.56
Performance (%)
-67.49%
Price
12.09.25
€0.27
Summary
This prediction is currently active. Massive losses of -67.49% have been the result for the BUY prediction by Chardan_Capital. This prediction currently runs until 28.03.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Clearside Biomedical Inc | - | - |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Chardan_Capital for this prediction
In the thread Clearside Biomedical Inc diskutieren
Clearside Biomedical, Inc. (NASDAQ: CLSD) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $6.00 price target on the stock.
Ratings data for CLSD provided by MarketBeat
Stopped prediction by Chardan_Capital for Clearside Biomedical Inc
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€1.04
14.10.24
14.10.24
€5.50
14.10.25
14.10.25
-73.65%
15.10.25
15.10.25
Clearside Biomedical Inc
Start price
Target price
Perf. (%)
€0.88
21.08.24
21.08.24
€5.39
21.08.25
21.08.25
-61.59%
22.08.25
22.08.25